company background image
BIOPOR logo

BioPorto CPSE:BIOPOR Stock Report

Last Price

DKK 1.72

Market Cap

DKK 739.9m

7D

-1.0%

1Y

-21.9%

Updated

11 Dec, 2024

Data

Company Financials +

BIOPOR Stock Overview

An in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. More details

BIOPOR fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

BioPorto A/S Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BioPorto
Historical stock prices
Current Share PriceDKK 1.72
52 Week HighDKK 2.85
52 Week LowDKK 1.21
Beta1.17
11 Month Change-1.71%
3 Month Change-12.05%
1 Year Change-21.90%
33 Year Change-33.26%
5 Year Change-40.82%
Change since IPO-99.25%

Recent News & Updates

We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Oct 22
We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Recent updates

We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Oct 22
We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

Dec 25
We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

Jun 28
We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Feb 27
We're Hopeful That BioPorto (CPH:BIOPOR) Will Use Its Cash Wisely

Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

Oct 19
Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

We're Keeping An Eye On BioPorto's (CPH:BIOPOR) Cash Burn Rate

Jun 15
We're Keeping An Eye On BioPorto's (CPH:BIOPOR) Cash Burn Rate

Is BioPorto (CPH:BIOPOR) In A Good Position To Deliver On Growth Plans?

Feb 17
Is BioPorto (CPH:BIOPOR) In A Good Position To Deliver On Growth Plans?

Here's Why We're Not Too Worried About BioPorto's (CPH:BIOPOR) Cash Burn Situation

Oct 16
Here's Why We're Not Too Worried About BioPorto's (CPH:BIOPOR) Cash Burn Situation

Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

May 28
Companies Like BioPorto (CPH:BIOPOR) Are In A Position To Invest In Growth

BioPorto A/S' (CPH:BIOPOR) Path To Profitability

Mar 01
BioPorto A/S' (CPH:BIOPOR) Path To Profitability

We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

Jan 24
We Think BioPorto (CPH:BIOPOR) Needs To Drive Business Growth Carefully

A Look At BioPorto's (CPH:BIOPOR) CEO Remuneration

Dec 20
A Look At BioPorto's (CPH:BIOPOR) CEO Remuneration

The BioPorto A/S (CPH:BIOPOR) Analysts Have Been Trimming Their Sales Forecasts

Nov 23
The BioPorto A/S (CPH:BIOPOR) Analysts Have Been Trimming Their Sales Forecasts

BioPorto A/S (CPH:BIOPOR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Nov 21
BioPorto A/S (CPH:BIOPOR) Analysts Are Cutting Their Estimates: Here's What You Need To Know

Shareholder Returns

BIOPORDK BiotechsDK Market
7D-1.0%2.6%-0.3%
1Y-21.9%-0.9%15.3%

Return vs Industry: BIOPOR underperformed the Danish Biotechs industry which returned -0.9% over the past year.

Return vs Market: BIOPOR underperformed the Danish Market which returned 15.3% over the past year.

Price Volatility

Is BIOPOR's price volatile compared to industry and market?
BIOPOR volatility
BIOPOR Average Weekly Movement6.0%
Biotechs Industry Average Movement7.6%
Market Average Movement4.3%
10% most volatile stocks in DK Market11.5%
10% least volatile stocks in DK Market2.6%

Stable Share Price: BIOPOR has not had significant price volatility in the past 3 months compared to the Danish market.

Volatility Over Time: BIOPOR's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
191736Peter Eriksenbioporto.com

BioPorto A/S, an in-vitro diagnostics company, provides biomarker tools and antibodies for clinical research in Europe, North America, Asia, and internationally. It offers the neutrophil gelatinase-associated lipocalin test, a quantitative particle-enhanced turbidimetric immunoassay designed to run on automated clinical chemistry analyzers; monoclonal antibodies for scientific, pharmaceutical, and clinical research; and enzyme-linked immunosorbent assay kits, as well as generic rapid assay device for custom lateral flow assays. BioPorto A/S was incorporated in 1917 and is based in Hellerup, Denmark.

BioPorto A/S Fundamentals Summary

How do BioPorto's earnings and revenue compare to its market cap?
BIOPOR fundamental statistics
Market capDKK 739.87m
Earnings (TTM)-DKK 61.30m
Revenue (TTM)DKK 34.91m

21.2x

P/S Ratio

-12.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOPOR income statement (TTM)
RevenueDKK 34.91m
Cost of RevenueDKK 10.05m
Gross ProfitDKK 24.86m
Other ExpensesDKK 86.16m
Earnings-DKK 61.30m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.14
Gross Margin71.22%
Net Profit Margin-175.62%
Debt/Equity Ratio0%

How did BIOPOR perform over the long term?

See historical performance and comparison